Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05914363Not ApplicableCompleted

Evaluating Impact of Improved Floors on Health

Role: collaborator

NCT06739629Not ApplicableCompleted

Refugee Insect Production for Food and Feed: the School Meal Intervention

Role: collaborator

NCT02259426Phase 3Completed

Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission

Role: collaborator

NCT01575613Not ApplicableCompleted

Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission

Role: collaborator

All 4 trials loaded